|The diarylquinoline TMC207 for multidrug-resistant tuberculosis|
AH Diacon, A Pym, M Grobusch, R Patientia, R Rustomjee, L Page-Shipp, ...
New England Journal of Medicine 360 (23), 2397-2405, 2009
|Multidrug-resistant tuberculosis and culture conversion with bedaquiline|
AH Diacon, A Pym, MP Grobusch, JM de los Rios, E Gotuzzo, I Vasilyeva, ...
New England Journal of Medicine 371 (8), 723-732, 2014
|14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial|
AH Diacon, R Dawson, F von Groote-Bidlingmaier, G Symons, A Venter, ...
The Lancet 380 (9846), 986-993, 2012
|Diagnostic tools in tuberculous pleurisy: a direct comparative study|
AH Diacon, BW Van de Wal, C Wyser, JP Smedema, J Bezuidenhout, ...
European Respiratory Journal 22 (4), 589-591, 2003
|Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug …|
AH Diacon, PR Donald, A Pym, M Grobusch, RF Patientia, R Mahanyele, ...
Antimicrobial agents and chemotherapy 56 (6), 3271-3276, 2012
|Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis|
R Rustomjee, AH Diacon, J Allen, A Venter, C Reddy, RF Patientia, ...
Antimicrobial agents and chemotherapy 52 (8), 2831-2835, 2008
|Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound|
AH Diacon, MH Brutsche, M Soler
Chest 123 (2), 436-441, 2003
|Treatment of highly drug-resistant pulmonary tuberculosis|
F Conradie, AH Diacon, N Ngubane, P Howell, D Everitt, AM Crook, ...
New England Journal of Medicine 382 (10), 893-902, 2020
|Bedaquiline in the treatment of multidrug-and extensively drug-resistant tuberculosis|
AS Pym, AH Diacon, SJ Tang, F Conradie, M Danilovits, C Chuchottaworn, ...
European Respiratory Journal 47 (2), 564-574, 2016
|Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis|
O Van Der Meeren, M Hatherill, V Nduba, RJ Wilkinson, M Muyoyeta, ...
New England Journal of Medicine 379 (17), 1621-1634, 2018
|High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial|
MJ Boeree, N Heinrich, R Aarnoutse, AH Diacon, R Dawson, S Rehal, ...
The Lancet infectious diseases 17 (1), 39-49, 2017
|A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis|
MJ Boeree, AH Diacon, R Dawson, K Narunsky, J Du Bois, A Venter, ...
American journal of respiratory and critical care medicine 191 (9), 1058-1065, 2015
|Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label …|
R Dawson, AH Diacon, D Everitt, C van Niekerk, PR Donald, DA Burger, ...
The Lancet 385 (9979), 1738-1747, 2015
|Intrapleural streptokinase for empyema and complicated parapneumonic effusions|
AH Diacon, J Theron, MM Schuurmans, BW Van de Wal, CT Bolliger
American journal of respiratory and critical care medicine 170 (1), 49-53, 2004
|Why do we use 600 mg of rifampicin in tuberculosis treatment?|
J Van Ingen, RE Aarnoutse, PR Donald, AH Diacon, R Dawson, ...
Clinical Infectious Diseases 52 (9), e194-e199, 2011
|Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis|
DR Tait, M Hatherill, O Van Der Meeren, AM Ginsberg, E Van Brakel, ...
New England Journal of Medicine 381 (25), 2429-2439, 2019
|Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients|
AH Diacon, R Dawson, M Hanekom, K Narunsky, A Venter, N Hittel, ...
The International journal of tuberculosis and lung disease 15 (7), 949-954, 2011
|Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears|
AH Diacon, RF Patientia, A Venter, PD Van Helden, PJ Smith, H McIlleron, ...
Antimicrobial agents and chemotherapy 51 (8), 2994-2996, 2007
|Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study|
JM Bryant, SR Harris, J Parkhill, R Dawson, AH Diacon, P van Helden, ...
The Lancet Respiratory Medicine 1 (10), 786-792, 2013
|Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients|
AH Diacon, R Dawson, M Hanekom, K Narunsky, SJ Maritz, A Venter, ...
Antimicrobial agents and chemotherapy 54 (8), 3402-3407, 2010